Presentation

Why are the data for Pretreatment Weak?

Presenter: Duane S. Pinto

February 08, 2016

REGISTER for free or LOG IN to view this content

Why are the data for Pretreatment Weak?

CAD Pharma

ACS/AMI

Presentation

Up Next

Presentation

Evaluation of High-Sensitivity Cardiac Troponin I Levels in Patients With Suspected ACS

Presenter: E. Carlton

June 02, 2016

More slides +

Presentation

Outcomes From Selective Use of Thrombectomy in Patients Undergoing Primary PCI for STEMI

Presenter: Alex Sirker

January 19, 2016

Presentation CTO 2016

The Retrograde Approach: Step by Step Instructions

Presenter: Stéphane Rinfret

February 25, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.